Berger, J. S., Laliberté, F., Kharat, A., Lejeune, D., Moore, K. T., Jung, Y., . . . Ashton, V. (2021). Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients with Obesity and Polypharmacy in the United States (US). Adv Ther.

Berger, Jeffrey S., François Laliberté, Akshay Kharat, Dominique Lejeune, Kenneth Todd Moore, Young Jung, Patrick Lefebvre, e Veronica Ashton. "Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients With Obesity and Polypharmacy in the United States (US)." Adv Ther 2021.

Berger, Jeffrey S., et al. "Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients With Obesity and Polypharmacy in the United States (US)." Adv Ther 2021.